Mercer Global Advisors Inc. ADV bought a new stake in shares of Globe Life Inc. (NYSE:GL - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 10,711 shares of the company's stock, valued at approximately $1,194,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of GL. Albion Financial Group UT purchased a new position in shares of Globe Life in the fourth quarter worth approximately $28,000. Rakuten Securities Inc. purchased a new position in shares of Globe Life during the 4th quarter worth $28,000. Avalon Trust Co bought a new stake in shares of Globe Life during the 4th quarter valued at $41,000. EverSource Wealth Advisors LLC increased its stake in shares of Globe Life by 32.7% in the 4th quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company's stock worth $41,000 after purchasing an additional 90 shares in the last quarter. Finally, Platinum Investment Management Ltd. bought a new position in Globe Life in the 4th quarter worth $45,000. 81.61% of the stock is owned by institutional investors.
Insider Buying and Selling
In other news, CEO James Matthew Darden sold 24,890 shares of the business's stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $121.52, for a total transaction of $3,024,632.80. Following the transaction, the chief executive officer now owns 38,973 shares of the company's stock, valued at approximately $4,735,998.96. The trade was a 38.97 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Frank M. Svoboda sold 11,000 shares of Globe Life stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $122.31, for a total transaction of $1,345,410.00. Following the transaction, the chief executive officer now directly owns 18,948 shares of the company's stock, valued at $2,317,529.88. The trade was a 36.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.51% of the stock is currently owned by company insiders.
Globe Life Stock Performance
Shares of NYSE GL opened at $121.97 on Friday. The company has a market cap of $10.15 billion, a P/E ratio of 10.21 and a beta of 0.56. Globe Life Inc. has a 52-week low of $76.55 and a 52-week high of $133.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05. The firm's fifty day moving average is $123.62 and its two-hundred day moving average is $117.13.
Globe Life (NYSE:GL - Get Free Report) last posted its earnings results on Wednesday, April 30th. The company reported $3.07 EPS for the quarter, missing analysts' consensus estimates of $3.24 by ($0.17). The firm had revenue of $1.48 billion during the quarter, compared to analysts' expectations of $1.49 billion. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. Globe Life's quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.78 earnings per share. As a group, analysts anticipate that Globe Life Inc. will post 13.87 EPS for the current fiscal year.
Globe Life Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Thursday, July 3rd will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.89%. The ex-dividend date of this dividend is Thursday, July 3rd. Globe Life's dividend payout ratio (DPR) is presently 8.79%.
Wall Street Analysts Forecast Growth
A number of analysts have commented on GL shares. Keefe, Bruyette & Woods upped their price target on Globe Life from $137.00 to $145.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 12th. JPMorgan Chase & Co. raised their target price on shares of Globe Life from $136.00 to $145.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. BMO Capital Markets initiated coverage on shares of Globe Life in a research report on Thursday, January 23rd. They issued a "market perform" rating and a $114.00 price target for the company. Morgan Stanley decreased their price objective on shares of Globe Life from $126.00 to $117.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. Finally, Piper Sandler lowered their target price on shares of Globe Life from $152.00 to $147.00 and set an "overweight" rating on the stock in a research note on Friday, May 2nd. Four investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $137.00.
Read Our Latest Report on Globe Life
Globe Life Company Profile
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.